|
|
|
|
|
|
PIOGLITAZONE
In medicine and pharmacology, pioglitazone is a member of the drug class of the thiazolidinediones.
It is being marketed as Actos® by the pharmaceutical companies Takeda and Eli Lilly.
Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.
Side-effects and contraindications
- See main article: thiazolidinedione
See also
External links
| Oral antidiabetic drugs (A10B) edit |
| Biguanides: |
Metformin |
| Sulfonylureas: |
Chlorpropamide, glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, Tolbutamide |
| Alpha-glucosidase inhibitor: |
Acarbose |
| Thiazolidinediones (TZD): |
Pioglitazone, Rosiglitazone, Troglitazone |
| Meglitinides: |
Nateglinide, Repaglinide |
| Dipeptidyl peptidase-4 (DPP-4) inhibitors: Sitagliptin, Vildagliptin |
|
|
|
|
|
|
|